JY
ARKG icon

Jeff Yass’s ARK Genomic Revolution ETF ARKG Stock Holding History

Jeff Yass’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.7M Buy
1,111,000
+9,900
+0.9% +$315K ﹤0.01% 1575
2026
Q1 		$29.1M Buy
1,101,100
+236,000
+27% +$6.91M ﹤0.01% 1773
2025
Q4 		$25.1M Buy
865,100
+281,600
+48% +$8.45M ﹤0.01% 1981
2025
Q3 		$16.2M Buy
583,500
+35,800
+7% +$905K ﹤0.01% 2428
2025
Q2 		$13.3M Buy
547,700
+62,700
+13% +$1.37M ﹤0.01% 2479
2025
Q1 		$10.1M Buy
485,000
+147,200
+44% +$3.7M ﹤0.01% 2525
2024
Q4 		$7.96M Sell
337,800
-52,100
-13% -$1.28M ﹤0.01% 2944
2024
Q3 		$9.98M Buy
389,900
+101,200
+35% +$2.58M ﹤0.01% 2618
2024
Q2 		$6.78M Sell
288,700
-137,600
-32% -$3.47M ﹤0.01% 2978
2024
Q1 		$12.3M Sell
426,300
-256,100
-38% -$7.7M ﹤0.01% 2348
2023
Q4 		$22.4M Buy
682,400
+514,600
+307% +$14M ﹤0.01% 1689
2023
Q3 		$4.67M Buy
167,800
+86,000
+105% +$2.81M ﹤0.01% 3650
2023
Q2 		$2.79M Sell
81,800
-28,200
-26% -$886K ﹤0.01% 4494
2023
Q1 		$3.31M Sell
110,000
-35,300
-24% -$1.09M ﹤0.01% 4134
2022
Q4 		$4.1M Buy
145,300
+7,200
+5% +$229K ﹤0.01% 3538
2022
Q3 		$4.54M Buy
138,100
+9,600
+7% +$352K ﹤0.01% 3316
2022
Q2 		$4.05M Sell
128,500
-463,100
-78% -$16.2M ﹤0.01% 3541
2022
Q1 		$27.2M Sell
591,600
-102,300
-15% -$4.88M ﹤0.01% 1419
2021
Q4 		$42.5M Sell
693,900
-352,900
-34% -$24.4M 0.01% 1213
2021
Q3 		$78.2M Sell
1,046,800
-545,000
-34% -$45.7M 0.01% 905
2021
Q2 		$147M Buy
1,591,800
+721,400
+83% +$61.3M 0.02% 632
2021
Q1 		$77.2M Buy
870,400
+657,300
+308% +$65.2M 0.01% 852
2020
Q4 		$19.9M Buy
+213,100
New +$17M ﹤0.01% 1744

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Jeff Yass's ARKG Position: Q2 2026 in Review

Jeff Yass reduced its ARK Genomic Revolution ETF (ARKG) stake by 51% in Q2 2026, selling an estimated $854K and leaving 26,018 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #7972.

Jeff Yass first reported a position in ARKG in Q3 2017 and has held it in 33 quarters since. The position peaked at $8.47M in Q1 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Jeff Yass held 26,018 shares of ARK Genomic Revolution ETF worth $1.09M as of Q2 2026.
  • Jeff Yass sold 26,816 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $854K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7972 holding.
  • Jeff Yass first reported a position in ARK Genomic Revolution ETF in Q3 2017 and has held it in 33 quarters since.
  • Jeff Yass's ARK Genomic Revolution ETF position peaked at $8.47M in Q1 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.